Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 09-2017 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,933 | -6,065 | -4,243 | -4,072 | -11,008 |
| Depreciation Amortization | 55 | 44 | N/A | N/A | N/A |
| Income taxes - deferred | -81 | -367 | N/A | N/A | N/A |
| Accounts receivable | -121 | 3 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 50 | -98 | N/A | -18 | 18 |
| Other Working Capital | 598 | 2,077 | 2,602 | 2,335 | 6,238 |
| Other Operating Activity | 297 | 3,506 | 156 | 156 | 1,277 |
| Operating Cash Flow | $-3,135 | $-901 | $-1,485 | $-1,599 | $-3,475 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -18 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | -156 | N/A | N/A | N/A |
| Other Investing Activity | -18 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-35 | $-156 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 658 | 181 | N/A | N/A | N/A |
| Debt Issued | 388 | 1,011 | 1,110 | N/A | N/A |
| Debt Repayment | 958 | -295 | N/A | N/A | N/A |
| Common Stock Issued | 1,084 | N/A | N/A | N/A | 2,350 |
| Other Financing Activity | 0 | 0 | 450 | 1,630 | 303 |
| Financing Cash Flow | $3,088 | $897 | $1,560 | $1,630 | $2,653 |
| Exchange Rate Effect | 0 | -4 | N/A | N/A | N/A |
| Beginning Cash Position | 243 | 407 | 19 | 174 | 995 |
| End Cash Position | 160 | 243 | 93 | 205 | 174 |
| Net Cash Flow | $-82 | $-164 | $75 | $31 | $-821 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,135 | -901 | -1,485 | -1,599 | -3,475 |
| Free Cash Flow | -3,135 | -901 | -1,485 | -1,599 | -3,475 |